The Hon. Michael Kirby
Chair of the Board
The Hon. Michael Kirby's distinguished career spans academia, business, provincial and federal services.
Dr. Randal Chase
Director
Dr. Chase has a wealth of experience in vaccines and has spent his entire career, spanning more than 30 years, in the biotechnology and pharmaceutical sectors.
Dr. William A. Cochrane
Director
Dr. Cochrane is well recognized as the founding Dean of Medicine for the Faculty of Medicine at the University of Calgary and a strong businessman in the biotechnology industry.
James W. Hall
Director
Jim Hall has over 25 years of international finance experience and serves as Chair of Immunovaccine’s audit committee.
Wade K. Dawe has been an entrepreneur in Canadian mining and venture capital industries since 1994. He has significant experience in public markets and finance and has served on the Board of ImmunoVaccine Inc. since 2005.
Albert Scardino is a communications strategist who brings his broad international network to Immunovaccine’s Board. He is a Pulitzer prize winning journalist and has been an advisor to the chairman of the US Securities and Exchange Commission.